SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...
SANTA CLARA, Calif., Jan. 08, 2024 -- January 8, 2024 – Shockwave Medical, Inc. , a pioneer in the development and commercialization of transformational technologies for the treatment of...
SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...
SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...
SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...
Shockwave C2+ Debut Joins Packed Shockwave Agenda at Transcatheter Cardiovascular Therapeutics Conference in San Francisco SANTA CLARA, Calif., Oct. 20, 2023 -- Shockwave Medical, Inc. , a...
/PRNewswire/ -- The "Global Transcatheter Devices Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19 and...
Shockwave Medical addresses cardiovascular disease treatments and recently acquired Neovasc with a promising market potential. Read more on SWAV stock here.
Growing prevalence of congenital heart disorders is expected to fuel the demand for pericardial patches. Increasing cases of hernias are anticipated to...
The global heart valve devices market is expected to increase due to advancements in structural heart systems as well as techniques including aortic valve...
Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to...
/PRNewswire/ -- The heart valve repair and replacement devices market size is set to grow by USD 3.01 billion from 2021 to 2026, progressing at a CAGR of 8.1%....